Skip to main content
    L

    Lineage Cell Therapeutics Inc (LCTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.99
    +0.07 (+7.76%)

    Market Cap: $229.72M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(26/39)
    Avg Surprise
    -26.81%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.04
    Range$-0.04 - $-0.03
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.03-16.7%
    60d ago$-0.03-16.7%
    30d ago$-0.040.0%
    7d ago$-0.040.0%
    Current$-0.04
    Revenue Consensus
    $2M
    Range$0 - $8M
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.03
    Range$-0.04 - $0.13
    4 analysts
    Revenue Consensus
    $9M
    Range$-3803860 - $30M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.03---
    Sep 26EST
    		-$-0.04---
    Jun 26
    Reported Aug 6
    		$-0.03$-0.03+0.00%Beat+76.9%
    Mar 26
    Reported May 12
    		$-0.03$-0.02-36.50%Miss-36.5%
    Dec 25
    Reported Mar 5
    		$0.00N/A+108.75%Beat+135.0%
    Sep 25
    Reported Nov 6
    		$-0.13$-0.03-333.33%Miss-550.0%
    Jun 25
    Reported Aug 12
    		$-0.13$-0.03-333.33%Miss-333.3%
    Mar 25
    Reported May 13
    		$-0.02$-0.03+33.33%Beat+50.0%
    Dec 24
    Reported Mar 10
    		$-0.01N/A+66.67%Beat+66.7%
    Sep 24
    Reported Nov 14
    		$-0.02$-0.03+33.33%Beat+50.0%
    Jun 24
    Reported Aug 8
    		$-0.03$-0.04+25.00%Beat+0.0%
    Mar 24
    Reported May 9
    		$-0.04$-0.04+0.00%Beat-33.3%
    Dec 23
    Reported Mar 7
    		$-0.03$-0.04+25.00%Beat+0.0%
    Sep 23
    Reported Nov 9
    		$-0.04$-0.03-33.33%Miss-33.3%
    Jun 23
    Reported Aug 10
    		$-0.03$-0.04+25.00%Beat+25.0%
    Mar 23
    Reported May 11
    		$-0.03$-0.05+40.00%Beat+25.0%
    Dec 22
    Reported Mar 9
    		$-0.03$-0.04+25.00%Beat+82.4%
    Sep 22
    Reported Nov 10
    		$-0.03$-0.04+25.00%Beat+0.0%
    Jun 22
    Reported Aug 11
    		$-0.04$-0.02-100.00%Miss+0.0%
    Mar 22
    Reported May 12
    		$-0.04$-0.06+33.33%Beat+20.0%
    Dec 21
    Reported Mar 10
    		$-0.17$-0.05-240.00%Miss-1800.0%
    Sep 21
    Reported Nov 10
    		$-0.03$-0.05+40.00%Beat+25.0%
    Jun 21
    Reported Aug 12
    		$-0.04$-0.04+0.00%Beat-33.3%
    Mar 21
    Reported May 13
    		$-0.05$-0.04-25.00%Miss+16.7%
    Dec 20
    Reported Mar 11
    		$0.01N/A+120.00%Beat+133.3%
    Sep 20
    Reported Nov 4
    		$-0.04$-0.04+0.00%Beat+20.0%
    Jun 20
    Reported Aug 6
    		$-0.03$-0.05+40.00%Beat+50.0%
    Mar 20
    Reported May 7
    		$-0.06$-0.03-100.00%Miss-20.0%
    Dec 19
    Reported Mar 12
    		$-0.03$-0.05+40.00%Beat+90.6%
    Sep 19
    Reported Nov 12
    		$-0.05$-0.05+0.00%Beat+37.5%
    Jun 19
    Reported Aug 8
    		$-0.06$-0.05-20.00%Miss+14.3%
    Mar 19
    Reported May 9
    		$-0.05$-0.06+16.67%Beat+50.0%
    Dec 18
    Reported Mar 14
    		$-0.32$-0.07-357.14%Miss+44.8%
    Sep 18
    Reported Nov 8
    		$-0.08$-0.06-33.33%Miss-125.8%
    Jun 18
    Reported Aug 2
    		$-0.07$-0.09+22.22%Beat-40.0%
    Mar 18
    Reported May 10
    		$-0.10$-0.07-42.86%Miss-42.9%
    Dec 17
    Reported Mar 15
    		$-0.58$-0.07-728.57%Miss-1060.0%
    Sep 17
    Reported Nov 9
    		$0.31$-0.08+487.50%Beat-
    Jun 17
    Reported Aug 2
    		$-0.05$-0.09+44.44%Beat-
    Mar 17
    Reported May 10
    		$-0.07$-0.09+22.22%Beat-
    Dec 16
    Reported Mar 16
    		$-0.05N/A+64.29%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E Ratio-5.38EV/EBITDAN/A
    Price/FCF-10.11xFCF Yield-9.89%
    Profitability
    Profit Margin-246.60%Operating Margin-835.00%
    ROE-60.10%ROIC-50.44%
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio6.61xQuick Ratio6.61x
    Trading Statistics
    Beta1.60Avg Volume1.70M
    52-Week High$2.0952-Week Low$0.88

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.95
    SMA 20$0.97
    SMA 50$1.04
    SMA 200$1.37
    EMA 10$0.96
    EMA 20$0.97
    EMA 50$1.03
    EMA 200$1.23

    MACD

    Line: -0.03Signal: -0.03Hist: 0.00

    ADX

    ADX: 13.1+DI: 20.6-DI: 21.0

    Aroon & PSAR

    Aroon Up16.0
    Aroon Down60.0
    PSAR$1.04

    Bollinger Bands

    Upper Band$1.05
    Lower Band$0.88
    %B Position1787%(Upper)
    Band Width0.63

    RSI (14-Day)

    Neutral
    50.1

    Momentum Oscillators

    Stoch %K34.3
    Stoch %D34.6
    Williams %R-34.6
    ROC (10d)9.3%
    Momentum0.08
    CCI (20d)1.4
    MFI (14d)43.8

    Volatility Measures

    ATR (14d)$0.06(6.4%)
    StdDev (20d)0.04
    Hist Vol74.6%(High)

    Volume Flow

    VWAP$0.97
    OBV41.3M
    AD Line-19.3M
    CMF (20d)-0.077

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio0.8x
    VWMA (20d)$0.97

    Pivot Points

    R3$0.99
    R2$0.97
    R1$0.94
    Pivot Point$0.92
    S1$0.89
    S2$0.87
    S3$0.84

    Advanced Oscillators

    TSI-12.23
    Ultimate Osc51.3
    KST-94.37

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.07M$1.73M$6.61M$3.68M$2.77M$1.50M$2.87M$3.78M$1.41M$1.44M$2.09M$1.25M
    Cost of Revenue$0$0$66,000$5,000$39,000$36,000$154,000$38,000$44,000$98,000$256,000$169,000
    Gross Profit$1.07M$1.73M$6.54M$3.68M$2.73M$1.47M$2.71M$3.74M$1.36M$1.35M$1.83M$1.08M
    Operating Expenses$9.99M$9.32M$13.09M$7.46M$22.51M$7.97M$7.82M$7.58M$7.23M$8.01M$8.19M$7.78M
    R&D$4.77M$4.23M$8.24M$3.27M$3.11M$3.11M$3.42M$3.17M$2.87M$3.01M$3.91M$3.74M
    SG&A$5.22M$5.08M$4.85M$4.19M$4.56M$4.86M$4.40M$4.41M$4.36M$5.00M$4.29M$4.04M
    Operating Income$-8,923,000$-7,593,000$-6,548,000$-3,786,000$-19,780,000$-6,505,000$-5,110,000$-3,840,000$-5,867,000$-6,661,000$-6,362,000$-6,705,000
    Interest Income$378,000$405,000$393,000$366,000$454,000$478,000$393,000$397,000$463,000$462,000$404,000$433,000
    Interest Expense$0$0$0$25.97M$0$0$0$0$0$0$0$453,000
    Income Before Tax$0$0$-4,388,000$-29,752,000$0$0$-3,250,000$-3,001,000$-5,773,000$-6,558,000$-4,714,000$-7,158,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$1.54M$-4,789,000$892,000$-29,752,000$-30,364,000$-4,143,000$-3,250,000$-3,001,000$-5,773,000$-6,558,000$-4,714,000$-7,158,000
    EBITDA$1.35M$-5,006,000$-4,595,000$-29,940,000$-30,647,000$-4,457,000$-3,492,000$-3,257,000$-6,094,000$-6,845,000$-4,943,000$-7,415,000
    EBIT$1.17M$-5,194,000$-4,781,000$-30,118,000$-30,818,000$-4,621,000$-3,643,000$-3,398,000$-6,236,000$-7,020,000$-5,118,000$-7,591,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LCTX

    LCTX Valuation and Fair Value

    P/E
    -5.4x
    Forward P/E
    30.7x
    P/FCF
    -10.1x
    PEG
    10.6x
    P/B
    4.0x
    See GNG's fair value

    LCTX Profitability: Margins, ROIC and FCF

    Gross margin
    99.5%
    Operating margin
    -835.0%
    Net margin
    -246.6%
    ROIC
    -50.4%
    ROE
    -60.1%
    FCF margin
    -186.4%
    FCF yield
    -9.9%

    LCTX Competitors

    CompanyTicker
    High Tide IncHITI
    Electromed IncELMD
    Immuneering CorpIMRX
    Zentalis Pharmaceuticals LlcZNTL
    Utah Medical Products IncUTMD
    Sol Gel Technologies LtdSLGL
    Q32 Bio IncQTTB
    Greenwich Lifesciences IncGLSI

    Sector: Healthcare

    LCTX Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    1
    Buy
    5
    Hold
    1
    Sell
    0
    Strong Sell
    0

    LCTX Bull Case vs Bear Case

    Bull case

    • 85.7% of LCTX's analyst ratings are Buy or Strong Buy.

    Bear case

    • LCTX has a -246.6% net profit margin.
    • LCTX's quarterly revenue changed -61.3% year over year.

    LCTX Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -57.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.04
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    LCTX Dividend

    Forward yield
    0.0%

    Frequently Asked Questions About LCTX

    Does LCTX pay dividends?

    Lineage Cell Therapeutics Inc (LCTX) has a dividend payment track record. See the LCTX dividend history page for its current payment status, TTM yield, and recorded payments.

    What is LCTX's market cap?

    Lineage Cell Therapeutics Inc (LCTX) has a market capitalization of $229.72M with a current stock price of $0.99.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In